These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 64234)

  • 21. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas.
    Greenberg AH; Miller V; Jablonski T; Pohajdak B
    J Immunol; 1984 Apr; 132(4):2129-34. PubMed ID: 6199424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophoretically pure mouse interferon exerts multiple biologic effects.
    Gresser I; De Maeyer-Guignard J; Tovey MG; De Maeyer E
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5308-12. PubMed ID: 291948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytes.
    Steuden J; Strzadała L; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):95-7. PubMed ID: 219815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
    Peeters P; Verloes R; Atassi G; Kanarek L
    Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
    Fleischmann WR
    Cancer Res; 1982 Mar; 42(3):869-75. PubMed ID: 6174218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparison of susceptibility of two target cells (HuRBC and L1210) to antibody dependent lymphocyte cytotoxicity.
    Wasik M; Górska B; Seyfried H
    Arch Immunol Ther Exp (Warsz); 1984; 32(6):641-8. PubMed ID: 6536235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of the antitumour effect of interferon in mice.
    Gresser I; Maury C; Brouty-Boyé D
    Nature; 1972 Sep; 239(5368):167-8. PubMed ID: 4561966
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological alteration of the antigenic properties of experimental leukemias detected by lymphocyte transformation].
    Testorelli C; Missiroli A; Di Padova F; Nicolin A
    Boll Ist Sieroter Milan; 1976; 55(2):142-50. PubMed ID: 1023882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of chemostat culture for the study of the effect of interferon on tumor cell multiplication.
    Tovey MG
    Methods Enzymol; 1981; 79(Pt B):391-404. PubMed ID: 6173686
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased binding of concanavalin A to interferon-treated murine leukemia L 1210 cells.
    Huet C; Gresser I; Bandu MT; Lindahl P
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):52-7. PubMed ID: 4438343
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon resistance in leukaemic cells and lysosome stability [proceedings].
    Wérenne J; Bartholeyns J
    Biochem Soc Trans; 1977; 5(4):1176-8. PubMed ID: 562295
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibition in vitro of multiplication of L 1210 murine leukemia cells by interferon preparations].
    Fontaine-Brouty-Boyé D; Gresser I; Macieira-Coelho A; Rosenfeld C; Thomas MT
    C R Acad Hebd Seances Acad Sci D; 1969; 269(3):406-8. PubMed ID: 4980277
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of leukaemia L1210 cells in culture: a comparison of clones differing in sensitivity to interferon.
    Wérenne J; Rousseau G
    Arch Int Physiol Biochim; 1976; 84(3):683-4. PubMed ID: 64234
    [No Abstract]   [Full Text] [Related]  

  • 39. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone.
    Nagase F; Rahman SM; Yokochi T; Kawashima K; Isobe K; Yoshida T; Nagura E; Nakashima I
    Cancer Res; 1987 Dec; 47(24 Pt 1):6494-9. PubMed ID: 3499976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhancement of the immune response following immunization with L1210 cells preliminarily incubated with interferon].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Jun; 81(6):706-7. PubMed ID: 953308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.